– Administered in 2x daily subcutaneous injections.
A proprietary diagnostic technology enables early diagnosis and disease tracking
Identification of the specific circulating antibodies for neurodegenerative diseases after indirect ELISA test and algorithm interpretation.
… to define the best combination of compounds …
![]() |
Fatty acids |
![]() |
Antioxidants |
![]() |
Free radical scavengers |
![]() |
Energy substrate |
![]() |
Essential amino acids |
A multi-target approach is needed for this multifactorial disease
PNS aims to counterbalance the multiple cellular metabolic defects of ALS and their consequences on motor-neurons, including :